コエンザイムAの代謝における対抗反応 酵素阻害に対するMycobacterium tuberculosisの感受性
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
PubMedで要約を見る
まとめ
この要約は機械生成です。新しい化合物は,Mycobacterium tuberculosisの脂質合成における重要な酵素であるフォスフォパントエニルトランスファーゼ (PptT) を阻害する. Pptヒドローラゼ (PptH) によって強化されたこの抑制は,結核に対する新しい戦略を提供します.
科学分野
- 微生物学
- 生物化学
- 薬物の発見
背景
- 結核菌 (Mycobacterium tuberculosis,Mtb) は,ヒトの感染症による死亡の主な原因である.
- Mtbの細胞壁と毒性は,リン酸合成に依存し,フォスフォパントエニルトランスファーゼ (PptT) に依存しています.
- PptTは,4'-フォスフォパンテイン (Ppt) をコエンザイムA (CoA) からアシルキャリアタンパク質に転送する.
研究 の 目的
- PptTを阻害する化合物を特定し,特徴づけること.
- MtbのPptT抑制に対する反応におけるPptヒドローラーゼ (PptH) の役割を調査する.
- 結核の新たな治療目標を探求するためです
主な方法
- PptT阻害のための化合物スクリーニング
- 酵素の活性と抑制を評価する生化学的測定法
- PptT阻害剤複合体の構造を決定する結晶学.
- PptH変異体の遺伝子解析
主要な成果
- PptTを部分的に抑制し,Mtbを殺す化合物が特定されました.
- PptT反応を逆転させる PptHによって化合物の有効性が強化されます.
- PptHの機能喪失による変異は,その化合物に対する耐性を引き出します.
- PptTと阻害剤の共結晶構造が得られた.
結論
- PptTは新しい抗菌剤の有効な標的薬である.
- PptTとPptHの対極的な作用は,CoA代謝における規制経路を示しています.
- PptT阻害剤の構造は,新しい結核治療の開発のための基盤を提供します.
関連する概念動画
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Competitive inhibitors occupy the active site of enzymes, making them unable to accommodate the substrate. However, sufficiently high...
Enzymes require additional components for proper function. There are two such classes of molecules: cofactors and coenzymes. Cofactors are metallic ions and coenzymes are non-protein organic molecules. Both of these types of helper molecule can be tightly bound to the enzyme or bound only when the substrate binds.
Cofactors are present in ~30% of mature proteins. They are frequently incorporated into an enzyme as it is folded and are involved in the enzyme’s catalytic activity. Magnesium...
Enzymes are proteins made of amino acids. The functional group of each constituent amino acid catalyzes a wide variety of chemical reactions via ionic interactions or acid-base reactions. However, amino acids cannot catalyze oxidation-reduction and group transfer reactions and need to be aided by non-protein components called cofactors. Cofactors are also referred to as the chemical teeth of an enzyme.
Cofactors can be metallic ions or organic molecules called coenzymes. These types of helper...
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
Since enzymes help control the rate of reactions, their activity is regulated so that appropriate amounts of starting materials, intermediate metabolites, and products are maintained in the cell. Excessive build-up or depletion of...
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...